PubRank

Lisa G Horvath

Author PubWeight™ 23.41‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Testing for ALK rearrangement in lung adenocarcinoma: a multicenter comparison of immunohistochemistry and fluorescent in situ hybridization. Mod Pathol 2013 2.55
2 Survival analysis of genome-wide gene expression profiles of prostate cancers identifies new prognostic targets of disease relapse. Cancer Res 2003 1.81
3 Identification of candidate biomarkers of therapeutic response to docetaxel by proteomic profiling. Cancer Res 2009 1.16
4 Prognostic factors in prostate cancer. Key elements in structured histopathology reporting of radical prostatectomy specimens. Pathology 2011 1.14
5 Expression of vascular endothelial growth factor receptor-3 by lymphatic endothelial cells is associated with lymph node metastasis in prostate cancer. Clin Cancer Res 2004 1.13
6 Pathways of chemotherapy resistance in castration-resistant prostate cancer. Endocr Relat Cancer 2011 1.07
7 Expression of the zinc transporter ZnT4 is decreased in the progression from early prostate disease to invasive prostate cancer. Oncogene 2003 1.06
8 Androgen regulation of multidrug resistance-associated protein 4 (MRP4/ABCC4) in prostate cancer. Prostate 2008 1.05
9 Global levels of specific histone modifications and an epigenetic gene signature predict prostate cancer progression and development. Cancer Epidemiol Biomarkers Prev 2010 1.05
10 Lymphatic vessel density and lymph node metastasis in prostate cancer. Prostate 2005 1.03
11 Zinc-alpha2-glycoprotein expression as a predictor of metastatic prostate cancer following radical prostatectomy. J Natl Cancer Inst 2006 1.03
12 Epigenetic deregulation across chromosome 2q14.2 differentiates normal from prostate cancer and provides a regional panel of novel DNA methylation cancer biomarkers. Cancer Epidemiol Biomarkers Prev 2010 0.97
13 Aberrant neuropeptide Y and macrophage inhibitory cytokine-1 expression are early events in prostate cancer development and are associated with poor prognosis. Cancer Epidemiol Biomarkers Prev 2006 0.97
14 Patterns of DNA mutations and ALK rearrangement in resected node negative lung adenocarcinoma. J Thorac Oncol 2013 0.93
15 Second opinions in oncology: the experiences of patients attending the Sydney Cancer Centre. Med J Aust 2009 0.87
16 High Gleason grade carcinoma at a positive surgical margin predicts biochemical failure after radical prostatectomy and may guide adjuvant radiotherapy. BJU Int 2011 0.86
17 Posterior reversible encephalopathy syndrome following chemotherapy with oxaliplatin and a fluoropyrimidine: a case report and literature review. Asia Pac J Clin Oncol 2012 0.85
18 Phosphoproteomic profiling identifies focal adhesion kinase as a mediator of docetaxel resistance in castrate-resistant prostate cancer. Mol Cancer Ther 2013 0.85
19 Low AZGP1 expression predicts for recurrence in margin-positive, localized prostate cancer. Prostate 2011 0.84
20 INPP4B is highly expressed in prostate intermediate cells and its loss of expression in prostate carcinoma predicts for recurrence and poor long term survival. Prostate 2014 0.82
21 Immunohistochemical level of unsulfated chondroitin disaccharides in the cancer stroma is an independent predictor of prostate cancer relapse. Cancer Epidemiol Biomarkers Prev 2008 0.82
22 Expression of phosphorylated-mTOR during the development of prostate cancer. Prostate 2014 0.79
23 Decision making in older patients with advanced cancer: does doctor know best? Med J Aust 2012 0.75
24 Stage migration in localized prostate cancer has no effect on the post-radical prostatectomy Kattan nomogram. BJU Int 2009 0.75